MedScout Raises $10M and Launches AI Agents for MedTech Commercial Teams 
GA-ASI Announces YFQ-42A Dark Merlin 
Triple Explosion: Spring Festival Gala, Livestreaming, and Offline Presence Trigger Value Realization for Shoucheng Holdings 
GA-ASI Develops Long-Range Weapons Capabilities for MQ-9B 
GA-ASI and USAF Demonstrate Manned-Unmanned Teaming With F-22 and MQ-20 In Joint Autonomy Exercise Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022
AI-driven discovery platform enables new way to find novel pathways as well as progress towards…
Rockley Photonics Announces Fourth Quarter and Full Year 2021 Financial Results
Customer Demand Drives Early Introduction of Bioptx™ Biomarker Sensing Platform, Adding Professional Healthcare Solution to…
Guidewire Announces Second Quarter Fiscal Year 2022 Financial Results
SAN MATEO, Calif.–(BUSINESS WIRE)–#Earnings–Guidewire (NYSE: GWRE) today announced its financial results for the fiscal quarter…
Elastic Announces New Capabilities to Help Customers Defend Against Cyber Attacks and Accelerate App Development
Introducing Expanded Data Integrations, Faster Indexing Speeds, and More Efficient Storage Utilization Introducing new prebuilt…
Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Annual Meeting
SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-Breaking Presentation at 2022 American Academy of Dermatology Annual Meeting
Oral presentation will include biomarker data from KARE Phase 2 clinical trial of Oral KORSUVA™…
Cannabis Industry Learnings Promote Change
Cannabis Authenticity and Purity Standard (CAPS) releases Issue 1.1 for certification GUELPH, Ontario, March 08,…
AIM ImmunoTech Announces Publication of Positive Data from Late-Stage Pancreatic Cancer Early Access Program (EAP) in the Cancers Special Issue: Combination and Innovative Therapies for Pancreatic Cancer
Ampligen® (rintatolimod) is being evaluated as a monotherapy to treat pancreatic cancer patients in an…
Ecoark Announces Successful Drilling of Louisiana Oil Well
SAN ANTONIO, March 08, 2022 (GLOBE NEWSWIRE) — Ecoark Holdings, Inc. (“Ecoark”) (NASDAQ: ZEST), today…
Ungerboeck Announces Integration Between VenueOps and Tessitura Platform
ST. LOUIS, March 08, 2022 (GLOBE NEWSWIRE) — Ungerboeck and Tessitura are pleased to announce…
The Essential Coin Is Succeeding in Their Mission to Provide the Most Secure Crypto Project Possible
Dallas, Texas–(Newsfile Corp. – March 8, 2022) – The Essential Coin team is happy to…
ConocoPhillips Announces Pricing of Cash Tender Offer
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) (“COP”) announced today the pricing terms of the previously announced tender…
ConocoPhillips Announces Pricing Terms for Debt Exchange Offers
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) (“COP”) announced today the pricing terms with respect to its private…
Audio-Based App Swell Launches New UX Design Now Available on iOS and Android
VIDEO HERE SCREENSHOTS HERE San Francisco Startup Champions Connection & Conversation Based On Quality Vs….
Apple Introduces the Most Powerful and Versatile iPad Air Ever
The new iPad Air features the breakthrough M1 chip, ultra-fast 5G, a new front camera…
Apple Unveils All-New Mac Studio and Studio Display
Mac Studio with M1 Max and the new M1 Ultra delivers unprecedented performance and extensive…
KBRA Assigns Preliminary Ratings to Lakeview Trust 2022-EBO1 (BVEBO 2022-1)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 6 classes of notes from Lakeview Trust 2022-EBO1…
Apple Introduces Gorgeous New Green Finishes for the iPhone 13 Lineup
New, sophisticated alpine green iPhone 13 Pro and green iPhone 13 join the lineup, featuring…
Adaptimmune to Report Q4 and Full Year 2021 Financial Results and Business Updates on Monday, March 14, 2022
PHILADELPHIA and OXFORDSHIRE, United Kingdom, March 08, 2022 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
Akari Therapeutics, Plc Announces $9.0 Million Registered Direct Offering
NEW YORK and LONDON, March 08, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX)…